Activity of Phage and Vancomycin in a Murine Staphylococcus aureus Periprosthetic Joint Infection Model Managed With Debridement and Implant Retention
Journal of Orthopaedic Research · 2025
DOI: 10.1002/jor.70029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Orthopaedic Research, 2025. Verfasst von Sebastian C Herren und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Vancomycin, Prosthesis-Related Infections, Staphylococcal Infections, Debridement. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: This study was supported by Center for Clinical and Translational Science, Mayo Clinic., Center for Clinical and Translational Science, Mayo Clinic.
Abstract (Originalsprache)
Periprosthetic joint infection (PJI) is a serious complication of total joint arthroplasty (TJA), with Staphylococcus aureus being one of the most common causative organisms. Irrigation and debridement with component retention (IDCR) is often performed to manage PJI. Antimicrobial treatment that targets S. aureus biofilms on prosthesis surfaces and within bone may be especially helpful when retaining a prosthesis. Phages, viruses that specifically infect bacteria, are a potential therapeutic consideration. Using a biofilm time kill assay in bovine synovial fluid, bactericidal activity of vancomycin or phage K (32 µg/mL and 10 11 pfu/mL, respectively) as well as the combination of phage K (10 10 pfu/mL) and vancomycin (32 µg/mL) was observed against a methicillin‐resistant S. aureus (MRSA) strain. Using a murine PJI model, mice infected with MRSA underwent IDCR followed by phage administration into the joint space with or without systemically administered vancomycin. Mice receiving both phage and vancomycin had significant reductions in MRSA on the prosthesis surface compared to untreated or vancomycin‐treated mice. Phage K showed bactericidal activity in vitro and was active when locally delivered in combination with systemically administered vancomycin in a murine PJI model managed with IDCR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
- Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
- Division of Public Health, Infectious Diseases, and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Sebastian C Herren, Sergio F Guarin Perez, Robin Patel, Nicholas A Bedard
Förderung
- This study was supported by Center for Clinical and Translational Science, Mayo Clinic.
- Center for Clinical and Translational Science, Mayo Clinic
Zitieren
APA
Herren, S. C., Karau, M. J., Guarin Perez, S. F., Koscianski, C. A., Mandrekar, J., Patel, R., & Bedard, N. A. (2025). Activity of Phage and Vancomycin in a Murine Staphylococcus aureus Periprosthetic Joint Infection Model Managed With Debridement and Implant Retention. Journal of Orthopaedic Research. https://doi.org/10.1002/jor.70029
Vancouver
Herren SC, Karau MJ, Guarin Perez SF, Koscianski CA, Mandrekar J, Patel R, et al. Activity of Phage and Vancomycin in a Murine Staphylococcus aureus Periprosthetic Joint Infection Model Managed With Debridement and Implant Retention. Journal of Orthopaedic Research. 2025. doi:10.1002/jor.70029
BibTeX
@article{Herren2025,
author = {Herren, Sebastian C and Karau, Melissa J and Guarin Perez, Sergio F and Koscianski, Christina A and Mandrekar, Jay and Patel, Robin and Bedard, Nicholas A},
title = {Activity of Phage and Vancomycin in a Murine Staphylococcus aureus Periprosthetic Joint Infection Model Managed With Debridement and Implant Retention},
journal = {Journal of Orthopaedic Research},
year = {2025},
doi = {10.1002/jor.70029}
}
EUVIMED